How Can I Get Mounjaro for Weight Loss?

Last reviewed: July 17, 2026

Last updated: July 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide, originally developed as Mounjaro for type 2 diabetes, has emerged as a potent option for weight management because it activates two hormone pathways simultaneously—GLP-1 and GIP receptors—creating a stronger metabolic response than single-action medications. PlexusDx provides access to compounded tirzepatide injections for patients seeking personalized weight loss therapy without the need for insurance or expensive clinic visits. This guide explains how to get started with tirzepatide through PlexusDx and what to expect during your treatment journey.

What Is Tirzepatide and How Does It Work for Weight Loss?

Tirzepatide belongs to a class of medications called dual GLP-1/GIP receptor agonists, which means it stimulates two separate signaling pathways in your body. The GLP-1 pathway reduces appetite and slows stomach emptying, while the GIP pathway enhances insulin sensitivity and may increase calorie burning. Clinical trials showed that patients using tirzepatide lost approximately 20% of their body weight over 68 weeks, with sustained weight reduction maintained when treatment continued.

Unlike older weight loss medications that work through a single mechanism, tirzepatide's dual action provides a more comprehensive metabolic adjustment. This dual effect may explain why some patients experience more significant weight loss compared to single-receptor medications. The medication also helps stabilize blood sugar levels, which can reduce cravings for high-calorie foods throughout the day.

How to Access Tirzepatide Through PlexusDx

PlexusDx makes tirzepatide accessible by partnering with licensed 503A compounding pharmacies in all 50 states, eliminating geographic barriers and the need for traditional insurance coverage. The process begins with a simple online health assessment and consultation with a licensed prescriber who reviews your medical history, current medications, and weight loss goals. Once approved, your prescription is compounded at a licensed facility and shipped directly to your home—no membership fees or hidden costs.

PlexusDx compounded tirzepatide injections are $289/mo month-to-month, or from $249/mo on the 6-month plan, with your dose able to increase as your body adjusts without any change to your monthly price. This flat-rate pricing model means you won't face unexpected cost jumps as your prescriber optimizes your treatment dose. The medications are HSA and FSA eligible, providing additional savings opportunities for eligible patients.

Personalized Treatment With the Precision Peptide Genetic Test

PlexusDx offers an optional Precision Peptide Genetic Test ($298) that analyzes genetic variants in pathways controlling hunger, satiety, and metabolic rate. The test examines key variants including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313—genetic markers linked to how your body responds to GLP-1 and GIP receptor activation. By mapping 14 metabolic pathways and 150+ genetic insights, this test helps your PlexusDx prescriber tailor your medication choice and dosing strategy to your unique biology.

The PlexusDx Precision Peptide Genetic Test analyzes FTO — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

What to Expect During Your First Month of Tirzepatide Treatment

Most patients begin tirzepatide at a low starting dose and then increase gradually every two to four weeks based on tolerability and response. During week one, many people notice reduced appetite and increased fullness during meals—a signal that the medication is engaging your GLP-1 and GIP receptors. Some patients experience mild nausea, constipation, or temporary changes in taste, which typically diminish as your body adapts to the medication over the first few weeks.

Your PlexusDx prescriber will guide you through dose escalation by providing clear injection instructions and monitoring your progress through follow-up check-ins. Weight loss often becomes noticeable after the third or fourth week, with the most substantial changes occurring between weeks 6 and 16 of consistent treatment. Maintaining adequate hydration, eating protein-rich foods, and staying active during this adjustment period helps minimize side effects and maximize the medication's effectiveness.

Comparing Tirzepatide to Other GLP-1 Options

PlexusDx offers both tirzepatide and semaglutide in injectable and oral forms, allowing patients to choose the delivery method and medication class that fits their lifestyle. Semaglutide activates only the GLP-1 receptor, making it effective for appetite suppression but with a single mechanism of action. Tirzepatide's dual-receptor approach often produces more dramatic weight loss in clinical settings, though individual responses vary based on genetics, lifestyle, and starting weight.

For patients interested in combining both mechanisms, PlexusDx offers GLP-Squared Injection—a proprietary dual compound containing both semaglutide and tirzepatide—at $289/mo month-to-month, or from $249/mo on the 6-month plan. Oral versions of both tirzepatide and semaglutide are also available for patients who prefer daily tablets over weekly or bi-weekly injections. Your consultation with a PlexusDx prescriber will help determine which formulation aligns with your preferences and expected outcomes.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Do I need a prescription from my regular doctor to get tirzepatide from PlexusDx?

No. PlexusDx connects you with licensed prescribers who specialize in weight loss therapy and can evaluate your eligibility directly. You'll complete an online health assessment, and a PlexusDx-affiliated prescriber will issue your prescription if appropriate. This eliminates the need to convince your primary care doctor and removes delays in starting treatment.

How much weight can I expect to lose with tirzepatide?

Clinical trials showed an average 20% body weight reduction over 68 weeks with tirzepatide therapy. Individual results depend on starting weight, adherence to the medication, diet, exercise, and genetics. PlexusDx's Precision Peptide Genetic Test can provide insight into your pathway-level genetic baseline based on your metabolic pathways.

What does PlexusDx tirzepatide cost, and does price increase with my dose?

PlexusDx compounded tirzepatide injections are $289/mo month-to-month, or from $249/mo on the 6-month plan—and your price stays flat even as your dose increases. This means you can optimize your treatment without worrying about unexpected cost jumps. Medications are HSA and FSA eligible for additional savings.

Are there serious side effects I should worry about with tirzepatide?

Most side effects are mild and temporary, including nausea, constipation, and reduced appetite. Serious side effects are rare but can include pancreatitis or thyroid issues—which is why medical screening and ongoing prescriber monitoring are essential. PlexusDx prescribers screen for contraindications before approval and remain available during your treatment.

How does the Precision Peptide Genetic Test help me choose between tirzepatide and semaglutide?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Mounjaro For Weight Loss 2
• Weight Loss Mounjaro
• Mounjaro Weight Loss By Week
• Weight Loss Injections Mounjaro

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.